Ingel Therapeutics Revenue, Growth & Competitor Profile

Last updated:

Company Awards

VC / Private Equity
Venture Capital / Private Equity

Company Profile & Annual Report for Ingel Therapeutics

Access the complete profile.

Ingel Therapeutics Fast Facts

RevenueN/A    See Exact Annual Revenue
EmployeesN/AExact Company Size
Primary Industry N/A
Address127 Western Ave
Allston, MA 02134

Note: Revenues for privately held companies are statistical evaluations.


Ingel Therapeutics's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?
    • Ingel Therapeutics is classified as operating in the N/A industry, NAICS Code .


Investor Activity

Ingel Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
August 26, 2022 4 35%$1 MM
Complete list of funding rounds and total amounts in the Company Report




Nearby Competitors

These companies are similar in business line and location to Ingel Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
FIDELITY WORKPLACE SERVICESBoston, MA100 
LIBERTY MUTUAL INSURANCEBoston, MA85 
INTELYCAREQuincy, MA47 
MASS GENERAL BRIGHAMBoston, MA28 
STATE STREETQuincy, MA23 
AMERICAN TOWER ASSET SUB IILLCBoston, MA21 




Other Companies at 127 Western Ave, Allston MA

Company HeadquartersRevenue ($ MM)
GRO BIOSCIENCESAllston, MA100 
DAY ZERO DIAGNOSTICSAllston, MA67 
MANIFOLD BIOTECHNOLOGIESAllston, MA19 
STRM.BIOBoston, MA9 
METALMARK INNOVATIONS PBCBoston, MA4 


(0.3155 s)



Future Competition: Ingel Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Ingel Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Ingel Therapeutics Competitors